There were no differences in serum peptide (motilin, ghrelin, and GLP-1) between the two groups but a trend for less serum GLP-1 in patients with type II diabetes mellitus was observed (P = 0.098) (Figure 3). The gene discussed is MLN; the disease is type 2 diabetes mellitus.